
| ASSET | DATE | % RETURN |
|---|---|---|
QuantaSing Group Limited American Depositary Shares (QSG) | 12/27/2023 - 1/30/2024 | 142.17% |
Here (HERE) | 12/27/2023 - 1/30/2024 | 142.17% |
ADC Therapeutics (ADCT) | 12/27/2023 - 1/30/2024 | 94.55% |
Real Brokerage (REAX) | 12/27/2023 - 1/30/2024 | 87.9% |
Astria Therapeutics (ATXS) | 12/27/2023 - 1/30/2024 | 70.5% |
Dianthus Therapeutics (DNTH) | 12/27/2023 - 1/30/2024 | 69.22% |
Akso Health Group ADR (AHG) | 12/27/2023 - 1/30/2024 | 64.21% |
SEALSQ (LAES) | 12/27/2023 - 1/30/2024 | 62.5% |
Mereo BioPharma Group PLC ADR (MREO) | 12/27/2023 - 1/30/2024 | 62.34% |
Yirendai (YRD) | 12/27/2023 - 1/30/2024 | 59.54% |
PepGen (PEPG) | 12/27/2023 - 1/30/2024 | 53.94% |
Cullinan Oncology LLC (CGEM) | 12/27/2023 - 1/30/2024 | 49.28% |
Neuropace (NPCE) | 12/27/2023 - 1/30/2024 | 48.81% |
Kura Oncology (KURA) | 12/27/2023 - 1/30/2024 | 48.08% |
POET Technologies (POET) | 12/27/2023 - 1/30/2024 | 44.44% |
Alliance Entertainment Holding Corporation Class A Common Stock (AENT) | 12/27/2023 - 1/30/2024 | 44.44% |
Bright Minds Biosciences (DRUG) | 12/27/2023 - 1/30/2024 | 43.33% |
Kodiak Sciences (KOD) | 12/27/2023 - 1/30/2024 | 42.35% |
Verastem (VSTM) | 12/27/2023 - 1/30/2024 | 41.94% |
Trilogy Metals (TMQ) | 12/27/2023 - 1/30/2024 | 41.22% |
Intuitive Machines (LUNR) | 12/27/2023 - 1/30/2024 | 39.92% |
Keros Therapeutics (KROS) | 12/27/2023 - 1/30/2024 | 39.91% |
Qilian International (BGM) | 12/27/2023 - 1/30/2024 | 39.86% |
Abacus Life (ABL) | 12/27/2023 - 1/30/2024 | 38.68% |
Ardelyx (ARDX) | 12/27/2023 - 1/30/2024 | 36.91% |